2021
DOI: 10.1253/circj.cj-21-0431
|View full text |Cite
|
Sign up to set email alerts
|

JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
100
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 122 publications
(100 citation statements)
references
References 242 publications
(141 reference statements)
0
100
0
Order By: Relevance
“…The prevalence of heart failure is increasing, and optimal physical and medical prophylactic and therapeutic strategies are still to be determined. 1 3 Of note, the management of pulmonary congestion is important to improve mortality and morbidity, as well as patients’ quality of life. 4 In addition to appropriate diuretic therapy, appropriate body posture helps prevent worsening heart failure.…”
mentioning
confidence: 99%
“…The prevalence of heart failure is increasing, and optimal physical and medical prophylactic and therapeutic strategies are still to be determined. 1 3 Of note, the management of pulmonary congestion is important to improve mortality and morbidity, as well as patients’ quality of life. 4 In addition to appropriate diuretic therapy, appropriate body posture helps prevent worsening heart failure.…”
mentioning
confidence: 99%
“…It is recommended in the U.S. guidelines for the treatment of HFrEF to initiate and up-titrate beta-blockers to target doses before consideration of ivabradine initiation [7]. In the updated Japanese guideline, ivabradine is also recommended as an additional drug in treating HFrEF with sinus rhythm and heart rate of 75 beats/minutes or higher [4].…”
Section: Discussionmentioning
confidence: 99%
“…Here we report a case of heart failure with reduced ejection fraction (HFrEF) occurring during chemotherapy for breast cancer. HFrEF is defined as heart failure with a left ventricular ejection fraction (LVEF) less than 40% [4]. Since the patient did not tolerate standard medication for HFrEF, she was prescribed ivabradine, which greatly improved her cardiac function.…”
Section: Introductionmentioning
confidence: 99%
“…Patients with HF and recovered ejection fraction (HFrecEF) demonstrate relatively better clinical outcomes than patients with persistent HFrEF 2 6 . It was previously reported that the independent predictors for improving LVEF were young age, female sex, and an etiology of non-ischemic heart disease 3 , 6 , 7 . Meanwhile, the withdrawal of guideline-directed medical therapy (GDMT) for HF in patients with dilated cardiomyopathy and recovered LVEF led to relapse of cardiomyopathy 8 .…”
Section: Introductionmentioning
confidence: 97%